OWCP Stock Overview
Through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
OWC Pharmaceutical Research Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | -99.00% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| OWCP | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | 0% | 14.2% | 32.3% |
Return vs Industry: OWCP underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: OWCP underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| OWCP volatility | |
|---|---|
| OWCP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: OWCP's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine OWCP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Ziv Turner | www.owcpharma.com |
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system.
OWC Pharmaceutical Research Corp. Fundamentals Summary
| OWCP fundamental statistics | |
|---|---|
| Market cap | US$497.00 |
| Earnings (TTM) | -US$2.29m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs OWCP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OWCP income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.29m |
| Earnings | -US$2.29m |
Last Reported Earnings
Sep 30, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did OWCP perform over the long term?
See historical performance and comparison